NICA Stock Overview
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Nanologica AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr6.82 |
52 Week High | kr13.70 |
52 Week Low | kr6.28 |
Beta | 0.68 |
1 Month Change | -4.48% |
3 Month Change | -31.53% |
1 Year Change | -26.19% |
3 Year Change | -60.12% |
5 Year Change | 70.93% |
Change since IPO | -68.86% |
Recent News & Updates
Recent updates
Nanologica (STO:NICA) Is Making Moderate Use Of Debt
Oct 10Is Nanologica AB (publ) (STO:NICA) Trading At A 40% Discount?
Jun 12Does Nanologica (STO:NICA) Have A Healthy Balance Sheet?
Oct 20Nanologica (STO:NICA) Is Making Moderate Use Of Debt
Jun 23Is Nanologica (NGM:NICA) A Risky Investment?
Jan 03Is Nanologica (NGM:NICA) Weighed On By Its Debt Load?
Jun 14Shareholders Are Thrilled That The Nanologica (NGM:NICA) Share Price Increased 115%
Feb 23Shareholder Returns
NICA | SE Biotechs | SE Market | |
---|---|---|---|
7D | 4.9% | 0.2% | 2.0% |
1Y | -26.2% | 4.8% | 17.8% |
Return vs Industry: NICA underperformed the Swedish Biotechs industry which returned 4.8% over the past year.
Return vs Market: NICA underperformed the Swedish Market which returned 18% over the past year.
Price Volatility
NICA volatility | |
---|---|
NICA Average Weekly Movement | 10.3% |
Biotechs Industry Average Movement | 8.5% |
Market Average Movement | 6.1% |
10% most volatile stocks in SE Market | 13.1% |
10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: NICA's share price has been volatile over the past 3 months.
Volatility Over Time: NICA's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 14 | Andreas Bhagwani | https://www.nanologica.com |
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA (U)HPLC analytical columns.
Nanologica AB (publ) Fundamentals Summary
NICA fundamental statistics | |
---|---|
Market cap | kr246.52m |
Earnings (TTM) | -kr75.16m |
Revenue (TTM) | kr4.67m |
52.8x
P/S Ratio-3.3x
P/E RatioIs NICA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NICA income statement (TTM) | |
---|---|
Revenue | kr4.67m |
Cost of Revenue | kr4.75m |
Gross Profit | -kr76.00k |
Other Expenses | kr75.08m |
Earnings | -kr75.16m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | -2.08 |
Gross Margin | -1.63% |
Net Profit Margin | -1,608.67% |
Debt/Equity Ratio | -3,517.2% |
How did NICA perform over the long term?
See historical performance and comparison